Pluri (PLUR) Change in Cash (2010 - 2025)
Pluri (PLUR) posted quarterly Change in Cash of $257000.0 for Q4 2025, down 93.69% year-over-year from $4.1 million in Q4 2024, and up 116.06% quarter-over-quarter from -$1.6 million in Q3 2025.
Pluri (PLUR) Change in Cash (2010 - 2025) Analysis & Trends
Pluri (PLUR) has reported Change in Cash for 16 consecutive years, with $257000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Change in Cash fell 93.69% year-over-year to $257000.0; the TTM figure through Dec 2025 stood at -$2.4 million (down 235.09% YoY), while the FY2025 annual figure was -$475000.0, down 133.57% from the prior year.
- Change in Cash improved to $257000.0 in Q4 2025 per PLUR's latest filing, from -$1.6 million in the prior quarter.
- Across five years, Change in Cash topped out at $19.0 million in Q2 2021 and bottomed at -$16.6 million in Q3 2021.
- Historically, Change in Cash has averaged -$122350.0 across 5 years, with a median of $197000.0 in 2022.
- Annual changes were most pronounced in 2021 — Change in Cash soared 1262.05% — and 2024, when it tumbled 3461.86%.
- Pluri's Change in Cash stood at $4.0 million in 2021, then sank by 96.58% to $137000.0 in 2022, then jumped by 138.69% to $327000.0 in 2023, then jumped by 1145.87% to $4.1 million in 2024, then tumbled by 93.69% to $257000.0 in 2025.
- Business Quant data shows PLUR's Change in Cash at $257000.0 in Q4 2025, -$1.6 million in Q3 2025, and -$2.5 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Pluri | 16.21 Mn | 3.72 Mn | 86,000.00 | 257,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 257,000.00 |
| Sep 30, 2025 | -1.60 Mn |
| Jun 30, 2025 | -2.50 Mn |
| Mar 31, 2025 | 1.40 Mn |
| Dec 31, 2024 | 4.07 Mn |
| Sep 30, 2024 | -3.46 Mn |
| Jun 30, 2024 | -320,000.00 |
| Mar 31, 2024 | 1.51 Mn |
| Dec 31, 2023 | 327,000.00 |
| Sep 30, 2023 | -97,000.00 |
| Jun 30, 2023 | 1.67 Mn |
| Mar 31, 2023 | -5.59 Mn |
| Dec 31, 2022 | 137,000.00 |
| Sep 30, 2022 | -1.38 Mn |
| Jun 30, 2022 | -13.52 Mn |
| Mar 31, 2022 | 5.71 Mn |
| Dec 31, 2021 | 4.00 Mn |
| Sep 30, 2021 | -16.62 Mn |
| Jun 30, 2021 | 18.99 Mn |
| Mar 31, 2021 | 4.55 Mn |